Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma

This study is looking at giving a second infusion of a CAR-T cell therapy called Relma-cel to patients with B-cell lymphoma whose cancer progressed, stabilized without full remission, or partially responded after the first round of this treatment. **You may be eligible if...** - You are an adult with relapsed or treatment-resistant B-cell lymphoma - You have already completed an initial treatment course with Relma-cel (CAR-T therapy) - Your doctor has assessed your disease at least once since the first treatment - Your doctor recommends a second round based on your clinical situation - Enough Relma-cel is available for a second dose **You may NOT be eligible if...** - You have not previously received Relma-cel - You achieved a complete response (full remission) after the first infusion with no signs of relapse - Your health is too poor to tolerate another round of CAR-T therapy Talk to your doctor to see if this trial is right for you.